Literature DB >> 26613873

MR Imaging Biomarkers in Oncology Clinical Trials.

Richard G Abramson1, Lori R Arlinghaus2, Adrienne N Dula1, C Chad Quarles3, Ashley M Stokes1, Jared A Weis4, Jennifer G Whisenant1, Eduard Y Chekmenev5, Igor Zhukov6, Jason M Williams7, Thomas E Yankeelov8.   

Abstract

The authors discuss eight areas of quantitative MR imaging that are currently used (RECIST, DCE-MR imaging, DSC-MR imaging, diffusion MR imaging) in clinical trials or emerging (CEST, elastography, hyperpolarized MR imaging, multiparameter MR imaging) as promising techniques in diagnosing cancer and assessing or predicting response of cancer to therapy. Illustrative applications of the techniques in the clinical setting are summarized before describing the current limitations of the methods.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CEST; DCE-MR imaging; DSC-MR imaging; Diffusion; Elastography; Hyperpolarized; Multiparametric

Mesh：

Substances：

Year:  2016        PMID： 26613873      PMCID： PMC4667554          DOI： 10.1016/j.mric.2015.08.002

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN： 1064-9689            Impact factor:   2.266


  154 in total

1.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

2.  Sub-second proton imaging of 13C hyperpolarized contrast agents in water.

Authors:  Milton L Truong; Aaron M Coffey; Roman V Shchepin; Kevin W Waddell; Eduard Y Chekmenev
Journal:  Contrast Media Mol Imaging       Date:  2014-04-21       Impact factor: 3.161

3.  Detection of brown adipose tissue and thermogenic activity in mice by hyperpolarized xenon MRI.

Authors:  Rosa Tamara Branca; Ting He; Le Zhang; Carlos S Floyd; Matthew Freeman; Christian White; Alex Burant
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

4.  Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.

Authors:  Jerrold L Boxerman; Benjamin M Ellingson; Suriya Jeyapalan; Heinrich Elinzano; Robert J Harris; Jeffrey M Rogg; Whitney B Pope; Howard Safran
Journal:  Am J Clin Oncol       Date:  2017-06       Impact factor: 2.339

5.  Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.

Authors:  Ronan J Kelly; Arun Rajan; Jeremy Force; Ariel Lopez-Chavez; Corrine Keen; Liang Cao; Yunkai Yu; Peter Choyke; Baris Turkbey; Mark Raffeld; Liqiang Xi; Seth M Steinberg; John J Wright; Shivaani Kummar; Martin Gutierrez; Giuseppe Giaccone
Journal:  Clin Cancer Res       Date:  2011-01-11       Impact factor: 12.531

6.  Parahydrogen-induced polarization (PHIP) hyperpolarized MR receptor imaging in vivo: a pilot study of 13C imaging of atheroma in mice.

Authors:  Pratip Bhattacharya; Eduard Y Chekmenev; Wanda F Reynolds; Shawn Wagner; Niki Zacharias; Henry R Chan; Rolf Bünger; Brian D Ross
Journal:  NMR Biomed       Date:  2011-04-28       Impact factor: 4.044

7.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo.

Authors:  S D Wolff; R S Balaban
Journal:  Magn Reson Med       Date:  1989-04       Impact factor: 4.668

8.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

Authors:  Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

9.  MR elastography of liver tumors: preliminary results.

Authors:  Sudhakar K Venkatesh; Meng Yin; James F Glockner; Naoki Takahashi; Philip A Araoz; Jayant A Talwalkar; Richard L Ehman
Journal:  AJR Am J Roentgenol       Date:  2008-06       Impact factor: 3.959

10.  Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.

Authors:  Benjamin M Ellingson; Eunhee Kim; Davis C Woodworth; Helga Marques; Jerrold L Boxerman; Yair Safriel; Robert C McKinstry; Felix Bokstein; Rajan Jain; T Linda Chi; A Gregory Sorensen; Mark R Gilbert; Daniel P Barboriak
Journal:  Int J Oncol       Date:  2015-02-11       Impact factor: 5.650
View more
  15 in total

1.  Dynamic contrast-enhanced magnetic resonance imaging for evaluating early response to radiosurgery in patients with vestibular schwannoma.

Authors:  Halil Özer; Merve Yazol; Nesrin Erdoğan; Ömer Hakan Emmez; Gökhan Kurt; Ali Yusuf Öner
Journal:  Jpn J Radiol       Date:  2022-01-17       Impact factor: 2.374

2.  Quantitative diffusion MRI of the abdomen and pelvis.

Authors:  Diego Hernando; Yuxin Zhang; Ali Pirasteh
Journal:  Med Phys       Date:  2021-10-08       Impact factor: 4.506

3.  Machine learning improves classification of preclinical models of pancreatic cancer with chemical exchange saturation transfer MRI.

Authors:  Joshua M Goldenberg; Julio Cárdenas-Rodríguez; Mark D Pagel
Journal:  Magn Reson Med       Date:  2018-09-17       Impact factor: 4.668

4.  The effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains.

Authors:  Ryan T Woodall; Stephanie L Barnes; David A Hormuth; Anna G Sorace; C Chad Quarles; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2017-11-08       Impact factor: 4.668

5.  Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting.

Authors:  Anna G Sorace; Chengyue Wu; Stephanie L Barnes; Angela M Jarrett; Sarah Avery; Debra Patt; Boone Goodgame; Jeffery J Luci; Hakmook Kang; Richard G Abramson; Thomas E Yankeelov; John Virostko
Journal:  J Magn Reson Imaging       Date:  2018-03-23       Impact factor: 4.813

6.  Multimodal Molecular Imaging Detects Early Responses to Immune Checkpoint Blockade.

Authors:  Yu Saida; Jeffrey R Brender; Kazutoshi Yamamoto; James B Mitchell; Murali C Krishna; Shun Kishimoto
Journal:  Cancer Res       Date:  2021-04-09       Impact factor: 13.312

Review 7.  Quantitative magnetic resonance imaging biomarkers in oncological clinical trials: Current techniques and standardization challenges.

Authors:  Jie Deng; Yi Wang
Journal:  Chronic Dis Transl Med       Date:  2017-03-11

8.  Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging.

Authors:  Stefanie J Hectors; Mathilde Wagner; Octavia Bane; Cecilia Besa; Sara Lewis; Romain Remark; Nelson Chen; M Isabel Fiel; Hongfa Zhu; Sacha Gnjatic; Miriam Merad; Yujin Hoshida; Bachir Taouli
Journal:  Sci Rep       Date:  2017-05-26       Impact factor: 4.996

Review 9.  Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy.

Authors:  Gigin Lin; Kayvan R Keshari; Jae Mo Park
Journal:  Contrast Media Mol Imaging       Date:  2017-10-09       Impact factor: 3.161

Review 10.  Medical physics challenges in clinical MR-guided radiotherapy.

Authors:  Christopher Kurz; Giulia Buizza; Guillaume Landry; Florian Kamp; Moritz Rabe; Chiara Paganelli; Guido Baroni; Michael Reiner; Paul J Keall; Cornelis A T van den Berg; Marco Riboldi
Journal:  Radiat Oncol       Date:  2020-05-05       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.